44 related articles for article (PubMed ID: 15464084)
21. Up-Regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth.
Nör JE; Christensen J; Liu J; Peters M; Mooney DJ; Strieter RM; Polverini PJ
Cancer Res; 2001 Mar; 61(5):2183-8. PubMed ID: 11280784
[TBL] [Abstract][Full Text] [Related]
22. Thalidomide inhibits growth of tumors through COX-2 degradation independent of antiangiogenesis.
Du GJ; Lin HH; Xu QT; Wang MW
Vascul Pharmacol; 2005 Aug; 43(2):112-9. PubMed ID: 15982930
[TBL] [Abstract][Full Text] [Related]
23. Basic fibroblast growth factor downregulates Bcl-2 and promotes apoptosis in MCF-7 human breast cancer cells.
Wang Q; Maloof P; Wang H; Fenig E; Stein D; Nichols G; Denny TN; Yahalom J; Wieder R
Exp Cell Res; 1998 Jan; 238(1):177-87. PubMed ID: 9457070
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of taspine on mouse S180 sarcoma and its mechanism].
Zhang YM; He LC; Wang HY
Zhongguo Zhong Yao Za Zhi; 2007 May; 32(10):953-6. PubMed ID: 17655156
[TBL] [Abstract][Full Text] [Related]
25. The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression.
Litz J; Sakuntala Warshamana-Greene G; Sulanke G; Lipson KE; Krystal GW
Lung Cancer; 2004 Dec; 46(3):283-91. PubMed ID: 15541812
[TBL] [Abstract][Full Text] [Related]
26. Tumour's angiogenesis--the function of VEGF and bFGF in colorectal cancer.
Kos M; Dabrowski A
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):556-61. PubMed ID: 12898895
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin analogues: multiple roles in cellular proliferation, neoplasia, and angiogenesis.
Dasgupta P
Pharmacol Ther; 2004 Apr; 102(1):61-85. PubMed ID: 15056499
[TBL] [Abstract][Full Text] [Related]
28. The control of angiogenesis and tumor invasion by platelet factor-4 and platelet factor-4-derived molecules.
Bikfalvi A; Gimenez-Gallego G
Semin Thromb Hemost; 2004 Feb; 30(1):137-44. PubMed ID: 15034805
[TBL] [Abstract][Full Text] [Related]
29. Mechanism of basic fibroblast growth factor-induced cell death.
Burchill SA; Westwood G
Apoptosis; 2002 Feb; 7(1):5-12. PubMed ID: 11773700
[TBL] [Abstract][Full Text] [Related]
30. Far beyond anti-angiogenesis: Benefits for anti-basicFGF therapy in cancer.
Li C; Kuang K; Du J; Eymin B; Jia T
Biochim Biophys Acta Mol Cell Res; 2022 Jul; 1869(7):119253. PubMed ID: 35259425
[TBL] [Abstract][Full Text] [Related]
31. Development of angiogenesis inhibitors for clinical applications.
Maione TE; Sharpe RJ
Trends Pharmacol Sci; 1990 Nov; 11(11):457-61. PubMed ID: 1702563
[TBL] [Abstract][Full Text] [Related]
32. Polyanionic drugs and viral oncogenesis: a novel approach to control infection, tumor-associated inflammation and angiogenesis.
Urbinati C; Chiodelli P; Rusnati M
Molecules; 2008 Nov; 13(11):2758-85. PubMed ID: 19002078
[TBL] [Abstract][Full Text] [Related]
33. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
